List view / Grid view
18 July 2019 | By Victoria Rees (European Pharmaceutical Review)
An Indian pharmaceutical company was planning to shred quality control records ahead of an FDA inspection, found officials.
15 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Amgen has successfully blocked the manufacture, sales and marketing of its Sanofi drug rival in Germany.
14 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The global controlled release drug delivery market will be worth an estimated $91.2 billion by 2026, according to a new study.
13 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has released draft guidance for using the Inactive Ingredients Database to aid drug developers.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
A pharmaceutical manufacturing site in New Jersey receives FDA warning letter for failing to thoroughly investigate quality problems and data integrity issues.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The global generic drugs market continues to grow. With increasing demand for more accessible medication, pharmaceutical companies are harnessing the benefits offered by generic drugs. Here are the top five generic drugs makers by revenue.
12 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
10 July 2019 | By Chemspec Europe 2019
The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. From 26 to 27 June 2019, a total of 379 exhibitors from 27 countries presented their innovative substances on a record net…
9 July 2019 | By European Pharmaceutical Review
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
4 July 2019 | By Victoria Rees (European Pharmaceutical Review)
A study has shown that crystallising drugs removes localised immune reaction, allowing long-term release of drugs from medical devices.
3 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The filler market is predicted to increase to US$2 billion by 2024, according to a new report.
3 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
2 July 2019 | By European Pharmaceutical Review
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
1 July 2019 | By Dana Barrasso, Debbie Hooper, Gavin Reynolds, Hervé Barjat, John Henderson, Mike Tobyn
New digital design and manufacturing techniques offer pharmaceutical manufacturers the possibility of a systems-based, digital approach to substantially streamline their design, development and manufacturing processes. The ADDoPT collaborative consortium has been working to explore how emerging process understanding and predictive models can be applied and embedded within industrial workflows to…
26 June 2019 | By Merck
Standardization and alignment of the drug development and manufacturing process allow high-performing companies to globally source and efficiently produce pharmaceutical and biopharmaceutical products.
Follow: